{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:35:55Z","timestamp":1793885755410,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jtct.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:49:39Z","timestamp":1784098179000},"page":"1461.e1-1461.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior Outcomes"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-5357","authenticated-orcid":false,"given":"Krischan","family":"Braitsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Hefter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6001-0601","authenticated-orcid":false,"given":"Christoph","family":"Nuernbergk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3704-5715","authenticated-orcid":false,"given":"Nancy Carolina","family":"Corredor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bassermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6276-8002","authenticated-orcid":false,"given":"Katharina S.","family":"G\u00f6tze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Herhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtct.2026.07.012_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1704338","article-title":"Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome","volume":"33","author":"Mitchell","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.012_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s15010-011-0229-y","article-title":"Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients","volume":"40","author":"Mikulska","year":"2012","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.jtct.2026.07.012_bib0003","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.012_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41409-022-01851-y","article-title":"Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss transplant cohort study: trends of causative pathogens and resistance rates","volume":"58","author":"Sava","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.012_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bmt.1705690","article-title":"Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality","volume":"40","author":"Poutsiaka","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.07.012_bib0006","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/bmt.2017.14","article-title":"Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis","volume":"52","author":"Dandoy","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.012_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jtct.2026.07.012_bib0008","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000535119","article-title":"Fluoroquinolone prophylaxis during conventional chemotherapy or hematopoietic stem cell transplantation for acute leukemia: pros and cons","volume":"147","author":"Hoffman","year":"2024","journal-title":"Acta Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.012_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17188","article-title":"Analysis of antibiotic exposure and development of acute graft-vs-host disease following allogeneic hematopoietic cell transplantation","volume":"6","author":"Rashidi","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jtct.2026.07.012_bib0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.07.012_bib0011","unstructured":"U.S. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. FDA Drug Safety Communication. July 10, 2018. Available at:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side-effects."},{"issue":"25","key":"10.1016\/j.jtct.2026.07.012_bib0013","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jtct.2026.07.012_bib0014","article-title":"Impact of discontinuing levofloxacin prophylaxis on bloodstream infections in neutropenic hematopoietic stem cell transplantation patients","volume":"11","author":"Guimar\u00e3es","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"12","key":"10.1016\/j.jtct.2026.07.012_bib0015","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1093\/jac\/dkae360","article-title":"Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study","volume":"79","author":"Stern","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jtct.2026.07.012_bib0016","doi-asserted-by":"crossref","first-page":"1195.e1","DOI":"10.1016\/j.jtct.2024.09.011","article-title":"Antibiotic prophylaxis during allogeneic stem cell transplantation: a comprehensive single center retrospective analysis","volume":"30","author":"Neuerburg","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.012_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14375","article-title":"Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis","volume":"26","author":"Nguyen","year":"2024","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.jtct.2026.07.012_bib0018","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1007\/s00277-024-05986-4","article-title":"Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration","volume":"103","author":"Toenges","year":"2024","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.012_bib0019","doi-asserted-by":"crossref","first-page":"168.e1","DOI":"10.1016\/j.jtct.2021.12.012","article-title":"Omitting ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and microbiome structure","volume":"28","author":"Daoud-Asfour","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.07.012_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/1078155218787286","article-title":"Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation","volume":"25","author":"Rambaran","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.012_bib0021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jinf.2020.11.002","article-title":"Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: risk factors and association with mortality","volume":"81","author":"Averbuch","year":"2020","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.012_bib0022","doi-asserted-by":"crossref","first-page":"50.e1","DOI":"10.1016\/j.jtct.2021.10.008","article-title":"Bloodstream infections and outcomes following allogeneic hematopoietic cell transplantation: a single-center study","volume":"28","author":"Carreira","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.07.012_bib0023","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jtct.2026.07.012_bib0024","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6469","key":"10.1016\/j.jtct.2026.07.012_bib0025","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","author":"Stein-Thoeringer","year":"2019","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jtct.2026.07.012_bib0026","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2026.07.012_bib0027","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2020.04.001","article-title":"Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis","volume":"26","author":"Hamadani","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.012_bib0028","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jtct.2021.03.015","article-title":"The effect of donor graft cryopreservation on allogeneic hematopoietic cell transplantation outcomes: a center for international blood and marrow transplant research analysis. implications during the COVID-19 pandemic","volume":"27","author":"Hsu","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"19","key":"10.1016\/j.jtct.2026.07.012_bib0029","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1182\/bloodadvances.2023009786","article-title":"Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic","volume":"7","author":"Devine","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jtct.2026.07.012_bib0030","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/ajh.27731","article-title":"Clinical impact of graft cryopreservation on allogeneic stem cell transplantation: an Italian, registry-based study on behalf of the \"Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare\" (GITMO)","volume":"100","author":"Defrancesco","year":"2025","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.jtct.2026.07.012_bib0031","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: challenges and progress","volume":"105","author":"Granot","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.012_bib0032","doi-asserted-by":"crossref","first-page":"183.e1","DOI":"10.1016\/j.jtct.2022.12.016","article-title":"Allogeneic hematopoietic stem cell transplantation in the outpatient setting: the mayo clinic experience","volume":"29","author":"Singhal","year":"2023","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600566X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600566X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:19:28Z","timestamp":1793884768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600566X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S266663672600566X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.012","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior Outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}